Global Dravet Syndrome Market: Industry Analysis & Outlook (2019-2023) – Attractive Orphan Drug Policies & Rising Strategic Alliances are Key Drivers – ResearchAndMarkets.com – Press Release

DUBLIN–(Business Wire)–The “Global
Dravet Syndrome Market: Industry Analysis Outlook (2019-2023)”

report has been added to ResearchAndMarkets.com’s
offering.

The disorder is considered orphan indication, and there are very limited
treatment options available in the market. However, several therapeutics
for Dravet syndrome are in pipeline. The drugs in development are
getting orphan drug designation by FDA and EMA.

The Dravet syndrome market in Europe and the U.S. is likely to exhibit
significant growth in the next five years due to increasing research and
development activities

... read more at: http://www.digitaljournal.com/pr/4143234

by

Leave a Reply